Eo 3 Eye Omega Advantage Interactions
There are 168 drugs known to interact with Eo 3 Eye Omega Advantage (cholecalciferol / lutein / omega-3 polyunsaturated fatty acids / zeaxanthin), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 11 are major, 155 are moderate, and 2 are minor.
- View all 168 medications that may interact with Eo 3 Eye Omega Advantage
- View Eo 3 Eye Omega Advantage alcohol/food interactions (1)
- View Eo 3 Eye Omega Advantage disease interactions (7)
Most frequently checked interactions
View interaction reports for Eo 3 Eye Omega Advantage (cholecalciferol / lutein / omega-3 polyunsaturated fatty acids / zeaxanthin) and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- amoxicillin / clavulanate
- atorvastatin
- Basaglar (insulin glargine)
- black cohosh
- calcium carbonate
- cetirizine
- chondroitin / glucosamine
- CoQ10 (ubiquinone)
- D3 (cholecalciferol)
- Dymista (azelastine / fluticasone nasal)
- EnLyte (multivitamin with iron)
- Estrace Vaginal Cream (estradiol topical)
- famotidine
- glucosamine
- Jardiance (empagliflozin)
- Klisyri (tirbanibulin topical)
- Low Dose ASA (aspirin)
- magnesium oxide
- mometasone
- omeprazole
- pantoprazole
- perindopril
- red yeast rice
- Rhofade (oxymetazoline topical)
- Soolantra (ivermectin topical)
- triamcinolone topical
- Ultra Hair, Skin and Nails Plus Biotin (multivitamin with minerals)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Eo 3 Eye Omega Advantage alcohol/food interactions
There is 1 alcohol/food interaction with Eo 3 Eye Omega Advantage (cholecalciferol / lutein / omega-3 polyunsaturated fatty acids / zeaxanthin).
Eo 3 Eye Omega Advantage disease interactions
There are 7 disease interactions with Eo 3 Eye Omega Advantage (cholecalciferol / lutein / omega-3 polyunsaturated fatty acids / zeaxanthin) which include:
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- arrhythmias
- liver disease
- hepatobiliary dysfunction
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.